Allspring Global Investments’s Bio-Rad Laboratories Class A BIO Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q1	$23.9M	Sell	85,965 -43,246	-33%	-$12.5M	0.04%	489
2025 Q4	$39.4M	Sell	129,211 -5,556	-4%	-$1.73M	0.06%	355
2025 Q3	$40.2M	Buy	134,767 +4,262	+3%	+$1.16M	0.06%	354
2025 Q2	$32.4M	Sell	130,505 -5,442	-4%	-$1.29M	0.05%	393
2025 Q1	$32.6M	Sell	135,947 -7,790	-5%	-$2.34M	0.06%	388
2024 Q4	$46.9M	Sell	143,737 -4,985	-3%	-$1.69M	0.08%	312
2024 Q3	$49.8M	Sell	148,722 -7,691	-5%	-$2.44M	0.08%	316
2024 Q2	$42.7M	Sell	156,413 -7,370	-4%	-$2.14M	0.07%	343
2024 Q1	$56.6M	Sell	163,783 -2,344	-1%	-$771K	0.09%	285
2023 Q4	$53.6M	Buy	166,127 +17,341	+12%	+$5.44M	0.09%	299
2023 Q3	$53.3M	Sell	148,786 -86,117	-37%	-$33.2M	0.09%	275
2023 Q2	$89.1M	Sell	234,903 -24,299	-9%	-$9.89M	0.14%	172
2023 Q1	$124M	Sell	259,202 -12,785	-5%	-$5.98M	0.21%	113
2022 Q4	$114M	Buy	271,987 +5,282	+2%	+$2.13M	0.2%	127
2022 Q3	$111M	Buy	266,705 +34,780	+15%	+$17.3M	0.2%	124
2022 Q2	$115M	Sell	231,925 -51,665	-18%	-$26.9M	0.19%	130
2022 Q1	$160M	Buy	283,590 +26,539	+10%	+$16M	0.2%	123
2021 Q4	$194M	Buy	+257,051	New	+$192M	0.22%	115